CNMD vs CV: stock comparison and AI forecast
Conmed Corp (CNMD) and Capsovision, Inc (CV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CNMD Conmed Corp
- Market Cap
- $1.57B
- P/E Ratio
- 19.6x
- Size
- small-cap
- AI Forecast
CV Capsovision, Inc
- Price
- $6.20 -13.8% · 6M
- Market Cap
- $310M
- P/E Ratio
- 7.4x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CNMD is 5.1 times larger than CV by market capitalization ($1.57B against $310M).
- CV trades at 7.4 times trailing earnings, CNMD at 19.6 times.
- CNMD carries 1.17 times debt per unit of equity, against 0.41 times for CV.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CNMD | CV |
|---|---|---|
| Market Cap | $1.57B | $310M |
| P/E Ratio | 19.57x | 7.38x |
| P/B Ratio | 1.49x | 23.57x |
| EPS | $2.70 | $0.84 |
| Book Value/Share | $35.56 | $0.26 |
| Revenue/Share | – | $0.33 |
| FCF/Share | – | $-0.56 |
Profitability & Margins
| Metric | CNMD | CV |
|---|---|---|
| ROE | 7.2% | – |
| ROA | 3.3% | – |
| ROIC | 8.0% | – |
| Gross Margin | 55.9% | 51.4% |
| Operating Margin | 8.6% | -213.1% |
| Net Margin | 4.5% | – |
| EBT Margin | 6.4% | -211.0% |
| Tax Rate | 30.2% | -0.1% |
Financial Health
| Metric | CNMD | CV |
|---|---|---|
| Current Ratio | 1.49x | 3.35x |
| Quick Ratio | 0.70x | 2.44x |
| D/E Ratio | 1.17x | 0.41x |
| Financial Leverage | 2.17x | 1.41x |
| Interest Coverage | 3.3x | -534.6x |
| Working Capital | $223M | $12M |
Cash Flow
| Metric | CNMD | CV |
|---|---|---|
| Operating Cash Flow | $200M | -$28M |
| Free Cash Flow | – | -$28M |
| Capital Spending | – | -$70K |
| OCF Growth YoY | 21.1% | – |
| FCF/Sales | – | -167.3% |
| CapEx/Sales | – | 0.4% |
Operational Efficiency
| Metric | CNMD | CV |
|---|---|---|
| Asset Turnover | – | 0.90x |
| Receivables Turnover | – | 7.4x |
| Inventory Turnover | 2.1x | 1.7x |
| Fixed Assets Turnover | – | 29.7x |
| Days Sales Outstanding | – | 50 days |
| Days Inventory | 176 days | 212 days |
| Payables Period | 48 days | 21 days |
| Cash Conversion Cycle | – | 240 days |
Income Statement
| Metric | CNMD | CV |
|---|---|---|
| Total Revenue | – | $17M |
| Operating Income | $147M | -$36M |
| Net Income | $76M | – |
| R&D Expense | $76M | $25M |
| SG&A Expense | $731M | $23M |
| Cost of Goods Sold | $753M | $8M |
Dividend & Shareholder Information
| Metric | CNMD | CV |
|---|---|---|
| Shares Outstanding | 30M | 50M |
| Net Income Growth | -30.8% | – |
| EPS Growth | -32.2% | – |
CNMD vs CV: stock comparison and AI forecast
Which is bigger, CNMD or CV?
CNMD is 5.1 times larger than CV by market capitalization ($1.57B against $310M).
Which is cheaper on earnings, CNMD or CV?
CV trades at 7.4 times trailing earnings, CNMD at 19.6 times.
Which one does Intratio's AI model rank higher, CNMD or CV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.